Healthcare Sector
Market Tracker
15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
| Expires | Type | Strike | OI | Change | Percent |
|---|---|---|---|---|---|
| 06/16/2023 | CALL | $2.50 | 0 | 0 | |
| 06/16/2023 | CALL | $5.00 | 0 | 0 | |
| 06/16/2023 | CALL | $7.50 | 0 | 0 | |
| 06/16/2023 | CALL | $10.00 | 0 | 0 | |
| 06/16/2023 | CALL | $12.50 | 1 | 0 | |
| 06/16/2023 | CALL | $15.00 | 0 | 0 | |
| 12/15/2023 | PUT | $17.50 | 1 | 0 | |
| 12/15/2023 | PUT | $20.00 | 2 | 0 | |
| 12/15/2023 | PUT | $22.50 | 0 | 0 | |
| 12/15/2023 | PUT | $25.00 | 0 | 0 | |
| 12/15/2023 | PUT | $30.00 | 0 | 0 | |
| 12/15/2023 | PUT | $35.00 | 0 | 0 |
Contracts with largest changes in open interest from the previous trading day to the current/most recent.
| Name | Pct Held | Shares | Total |
|---|---|---|---|
| Variable Insurance Products Fund-Growth Portfolio | 3.35% | 384.5k | 6.54M |
| Fidelity Capital Appreciation Fund | 2.58% | 296k | 5.03M |
| Fidelity Advisor Equity Growth Fund | 2.54% | 291.1k | 4.95M |
| Vanguard Total Stock Market Index Fund | 1.94% | 222k | 3.77M |
| Fidelity Growth Discovery Fund | 1.41% | 162.1k | 2.76M |
| Vanguard Extended Market Index Fund | 0.60% | 68.35k | 1.16M |
| Fidelity Advisor Series Equity Growth Fund | 0.49% | 55.68k | 946.51k |
| Fidelity Select Portfolios - Pharmaceuticals | 0.47% | 53.3k | 906.1k |
| Fidelity Extended Market Index Fund | 0.35% | 40.57k | 689.76k |
| Avantis U.S. Small Cap Value ETF | 0.23% | 26.05k | 442.85k |
XOMA Reports First Quarter 2023 Financial Results and Provides Update on the Acceleration of its Differentiated Royalty Monetization Strategy
05/09 07:30 am
GlobeNewswire Inc.
Read moreStrength Seen in Vertex (VRTX): Can Its 5.0% Jump Turn into More Strength?
04/28 03:28 am
Zacks Investment Research
Read moreXOMA to Present at H.C. Wainwright BioConnect Investor Conference
04/26 07:30 am
GlobeNewswire Inc.
Read moreXOMA Acquires Cashflow-Generating Asset for its Royalty and Milestone Portfolio
03/30 07:30 am
GlobeNewswire Inc.
Read moreXOMA Declares Quarterly Preferred Stock Dividends
03/21 07:30 am
GlobeNewswire Inc.
Read moreXOMA Reports Full-Year 2022 Financial Results and Provides Update to the Acceleration of its Differentiated Royalty Monetization Strategy
03/09 08:30 am
GlobeNewswire Inc.
Read moreXOMA to Present at 43rd Annual Cowen Health Care Conference
02/28 08:30 am
GlobeNewswire Inc.
Read moreXOMA Announces New Employment Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01/06 08:00 pm
GlobeNewswire Inc.
Read moreNew Executive Leadership Team Appointed to Accelerate XOMA’s Differentiated Royalty Monetization Strategy
01/04 08:30 am
GlobeNewswire Inc.
Read moreXOMA Declares Quarterly Preferred Stock Dividends
12/22 08:30 am
GlobeNewswire Inc.
Read moreXOMA Acquires Royalty and Milestone License to Ebopiprant, a Preterm Labor Asset, Being Developed by Organon
11/22 08:01 am
GlobeNewswire Inc.
Read moreXOMA Declares Quarterly Preferred Stock Dividends
09/21 07:30 am
GlobeNewswire Inc.
Read moreStarbucks And 3 Other Stock Insiders Are Buying
09/19 10:57 am
Benzinga
Read moreXOMA to Present at H.C. Wainwright 24th Annual Global Investment Conference
09/07 07:30 am
GlobeNewswire Inc.
Read moreXoma (XOMA) Reports Q2 Loss, Misses Revenue Estimates
08/04 10:45 am
Zacks Investment Research
Read moreXOMA Reports Second Quarter 2022 Financial Results and Highlights Recent Operational Events
08/04 07:30 am
GlobeNewswire Inc.
Read moreXOMA Declares Quarterly Preferred Stock Dividends
06/20 07:30 am
GlobeNewswire Inc.
Read moreXOMA to Present at H.C. Wainwright Global Investment Conference
05/17 04:05 pm
GlobeNewswire Inc.
Read moreXoma (XOMA) Reports Q1 Loss, Misses Revenue Estimates
05/05 08:55 am
Zacks Investment Research
Read moreKymera Therapeutics, Inc. (KYMR) Reports Q1 Loss, Lags Revenue Estimates
05/03 08:15 am
Zacks Investment Research
Read moreXOMA Declares Quarterly Preferred Stock Dividends
03/21 07:30 am
GlobeNewswire Inc.
Read moreXOMA to Present at the 42nd Annual Cowen Health Care Conference
03/01 08:30 am
GlobeNewswire Inc.
Read moreXOMA to Present at Aegis Capital Corp Investor Conference
02/17 08:30 am
GlobeNewswire Inc.
Read moreXOMA Declares Quarterly Preferred Stock Dividends
12/23 08:30 am
GlobeNewswire Inc.
Read moreXOMA to Present at Upcoming Investor Conferences
12/21 08:30 am
GlobeNewswire Inc.
Read moreXOMA Announces Evolution of Company Leadership and Succession Planning
12/16 08:30 am
GlobeNewswire Inc.
Read moreXoma (XOMA) Reports Q3 Loss, Misses Revenue Estimates
11/04 10:15 am
Zacks Investment Research
Read moreXOMA Earns $35 Million Milestone Payment as Anti-TGFβ Antibody Enters Phase 3 Clinical Study in Metastatic Pancreatic Cancer
11/04 07:40 am
GlobeNewswire Inc.
Read moreXOMA Reports Third Quarter 2021 Financial Results and Highlights Recent Operational Events
11/04 07:30 am
GlobeNewswire Inc.
Read moreStrength Seen in Xoma (XOMA): Can Its 11.2% Jump Turn into More Strength?
10/08 03:35 am
Investing.com
Read moreStrength Seen in Xoma (XOMA): Can Its 11.2% Jump Turn into More Strength?
10/08 03:35 am
Zacks Investment Research
Read moreXOMA to Present at the 2021 Cantor Fitzgerald Virtual Global Healthcare Conference
09/22 07:30 am
GlobeNewswire Inc.
Read moreXOMA Declares Quarterly Preferred Stock Dividends
09/20 07:30 am
GlobeNewswire Inc.
Read moreXOMA to Present at H.C. Wainwright 23rd Annual Global Investment Conference
09/13 07:30 am
GlobeNewswire Inc.
Read moreI Put Half Of My Retirement Savings Into These Investments
09/02 08:35 am
Seeking Alpha
Read moreXOMA Announces Heather L. Franklin Joins its Board of Directors
08/10 04:35 pm
GlobeNewswire Inc.
Read moreXoma (XOMA) Reports Q2 Loss, Misses Revenue Estimates
08/05 08:45 am
Zacks Investment Research
Read moreXOMA Reports Second Quarter 2021 Financial Results and Highlights Recent Operational Events
08/05 07:30 am
GlobeNewswire Inc.
Read moreEarnings Preview: Xoma (XOMA) Q2 Earnings Expected to Decline
07/29 03:05 pm
Zacks Investment Research
Read moreThe Daily Biotech Pulse: Galapagos Sinks On Data, J&J Recalls Sunscreen Products, FibroGen Awaits AdCom Verdict, 3 IPOs
07/15 08:07 am
Benzinga
Read moreXoma (XOMA) Reports Q1 Loss, Misses Revenue Estimates
05/06 09:15 am
Zacks Investment Research
Read more